Cargando…
Increased Healthcare Resource Use and Costs After Discontinuation of Liraglutide in Patients with Type 2 Diabetes from a Commercial- and Medicaid-Insured Claims Database
INTRODUCTION: Liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), is effective in patients with type 2 diabetes (T2D), but treatment discontinuation without new T2D therapy initiation may compromise outcomes. METHODS: This retrospective cohort study (July 1, 2012, to December 31, 201...
Autores principales: | Uzoigwe, Chioma, Noone, Josh, Liang, Yuanjie, Ali, Sarah Naz, Gamble, Cory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663787/ https://www.ncbi.nlm.nih.gov/pubmed/36239850 http://dx.doi.org/10.1007/s13300-022-01322-z |
Ejemplares similares
-
Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data
por: Tranby, Eric P., et al.
Publicado: (2022) -
Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations: Analysis of claims-based databases, 2006–2010
por: Krishnarajah, Girishanthy, et al.
Publicado: (2014) -
Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
por: Smoyer-Tomic, Karen E, et al.
Publicado: (2012) -
HIV Testing among Outpatients with Medicaid and Commercial Insurance
por: Dietz, Patricia M., et al.
Publicado: (2015) -
Alcohol-Attributable Medical Costs in Commercially Insured and Medicaid Populations
por: Ozluk, Pelin, et al.
Publicado: (2022)